Discovery of selective LATS inhibitors via scaffold hopping: enhancing drug-likeness and kinase selectivity for potential applications in regenerative medicine

Using scaffold hopping aided by docking studies and AI-assisted metabolic stability predictions, we identified a novel LATS inhibitor with potent kinase activity, high selectivity, and superior oral pharmacokinetic profiles.